⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 6, 2016Journal for ImmunoTherapy of CancerOpen Access

Biomarkers immune monitoring technology primer: Immunoscore® Colon

Fabienne Hermitte

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

The Immunoscore® assay for Colon Cancer (IS Colon) is the first standardized immune-based assay for the classification of cancer. It assesses the host immune response to Colon Cancer (CC) by measuring intra- and peri-tumoral T cell infiltration in formalin-fixed paraffin-embedded (FFPE) tissue

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Fabienne Hermitte (2016) studied this question.

synapsesocial.com/papers/6a5c12624a150f8e985ea0e8 https://doi.org/10.1186/s40425-016-0161-x

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Cancer classification using the Immunoscore: a worldwide task forceReview · 2012 · 792 citations
2The Adaptive Immunologic Microenvironment in Colorectal Cancer: A Novel PerspectivePrognostic Study · 2007 · 448 citations
3In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal CancerRetrospective Study · 2009 · 953 citations
4Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune ReactionPrognostic Study · 2011 · 1,005 citations
5The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasisOriginal Research · 2016 · 474 citations
6Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumoursOriginal Research · 2013 · 1,358 citations
7CD39, CD73, and CD38 track tumor burden and reveal immune remodeling during mogamulizumab therapy in Sézary syndromeJournal for ImmunoTherapy of Cancer · 2026
8Enhanced melanoma-specific cytotoxic T-cell expansion and the clinical outcomes with simlukafusp alfa and pembrolizumab following checkpoint inhibitor progressionJournal for ImmunoTherapy of Cancer · 2026
9Hormone therapy potentiates chemoimmunotherapy by inducing SUMOylation-mediated immunogenic cell deathJournal for ImmunoTherapy of Cancer · 2026
10Propionate promotes CD8 + T-cell infiltration and enhances immunotherapy efficacy in colorectal cancerJournal for ImmunoTherapy of Cancer · 2026

More from Journal for ImmunoTherapy of Cancer